Cargando…
Deubiquitinase MYSM1 in the Hematopoietic System and beyond: A Current Review
MYSM1 has emerged as an important regulator of hematopoietic stem cell function, blood cell production, immune response, and other aspects of mammalian physiology. It is a metalloprotease family protein with deubiquitinase catalytic activity, as well as SANT and SWIRM domains. MYSM1 normally localiz...
Autores principales: | Fiore, Amanda, Liang, Yue, Lin, Yun Hsiao, Tung, Jacky, Wang, HanChen, Langlais, David, Nijnik, Anastasia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216186/ https://www.ncbi.nlm.nih.gov/pubmed/32344625 http://dx.doi.org/10.3390/ijms21083007 |
Ejemplares similares
-
Loss of MYSM1 inhibits the oncogenic activity of cMYC in B cell lymphoma
por: Lin, Yun Hsiao, et al.
Publicado: (2021) -
Deubiquitinase catalytic activity of MYSM1 is essential in vivo for hematopoiesis and immune cell development
por: Liang, Yue, et al.
Publicado: (2023) -
Regulation of B Lymphocyte Development by Histone H2A Deubiquitinase BAP1
por: Lin, Yun Hsiao, et al.
Publicado: (2021) -
p53-dependent induction of P2X7 on hematopoietic stem and progenitor cells regulates hematopoietic response to genotoxic stress
por: Tung, Lin Tze, et al.
Publicado: (2021) -
Repression of p53-target gene Bbc3/PUMA by MYSM1 is essential for the survival of hematopoietic multipotent progenitors and contributes to stem cell maintenance
por: Belle, J I, et al.
Publicado: (2016)